Thymoorganon Pharmazie GmbH

The drug is used for the treatment of adults and children with widespread or metastatic cancer of the testis, ovary, bladder, non-small cell and small cell lung cancer, as well as squamous cell carcinoma of the head and neck. It is also used for cervical tumors in combination with radiotherapy.

Dosage form: concentrate for infusion solution

ATC: L01XA01

The drug is used to treat a wide range of neoplastic diseases, including acute leukemia, lymphoma, soft tissue sarcoma, and osteosarcoma, as well as malignant neoplasms in children and solid tumors in adults (e.g., breast and lung cancer).

Dosage form: solution for injection

ATC: L01DB01

The drug is used to treat patients with metastatic colorectal cancer. It may be prescribed as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.

Dosage form: concentrate for infusion solution

ATC: L01XX19*

The drug is prescribed for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (either in combination with cisplatin or as monotherapy for maintenance or second-line treatment).

Dosage form: powder for preparation of concentrate for infusion solution

ATC: L01BA04

The drug is prescribed for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line therapy).

Dosage form: powder for preparation of concentrate for infusion solution

ATC: L01BA04